Patrick Velliky, HaloMD's chief external affairs officer, is pushing back against critics of both his company and his analysis of the No Surprises Act. In an interview with Healthcare Dive, he said he is confident the law is reducing out-of-network spending, despite studies that suggest otherwise.
Velliky argues that critics have mischaracterized the data and the company's position. The article frames HaloMD as a target in the ongoing debate over surprise billing, with Velliky responding to accusations that his analysis is flawed and that the company's practices deserve scrutiny.
The disagreement hinges on how to interpret the law's effects. While Velliky maintains the No Surprises Act is working as intended, the research cited by his detractors tells a different story, leaving the question unresolved.